Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.33K Buy
+178
New +$9.41K ﹤0.01% 870
2025
Q3
Sell
-3,320
Closed -$128K 1174
2025
Q2
$128K Sell
3,320
-72
-2% -$2.75K 0.07% 225
2025
Q1
$131K Buy
3,392
+2,200
+185% +$80.5K 0.05% 294
2024
Q4
$42K Buy
+1,192
New +$42.9K 0.02% 473

Other funds holding GSK

AmeriFlex Group's GSK Position: Q2 2026 in Review

AmeriFlex Group opened a new position in GSK (GSK) in Q2 2026: 178 shares worth $9.33K. The stake represents ﹤0.01% of the portfolio and ranks #870 among its holdings. This is a return to the name: AmeriFlex Group previously reported a position in GSK as recently as Q2 2025.

AmeriFlex Group first reported a position in GSK in Q4 2024 and has held it in 4 quarters since. The position peaked at $131K in Q1 2025. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • AmeriFlex Group held 178 shares of GSK worth $9.33K as of Q2 2026.
  • GSK was a new AmeriFlex Group position in Q2 2026.
  • GSK made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #870 holding.
  • AmeriFlex Group first reported a position in GSK in Q4 2024 and has held it in 4 quarters since.
  • AmeriFlex Group's GSK position peaked at $131K in Q1 2025.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.